本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ChemoCentryx

51.99
0.0000
成交量:- -
成交額:- -
市值:37.39億
市盈率:-27.55
高:51.99
開:51.99
低:51.99
收:51.99
52周最高:51.99
52周最低:51.99
股本:7,191.97萬
流通股本:7,191.97萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.8873
每股收益(LYR):-1.8862
淨資產收益率:-46.96%
總資產收益率:-18.55%
市淨率:15.81
市盈率(LYR):-27.56

資料載入中...

2022/10/20

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/10/20

重要事件披露

8-K - Current report
2022/10/20

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/20

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/18

重要事件披露

8-K - Current report
2022/09/20

重要事件披露

8-K - Current report
2022/08/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

重要事件披露

8-K - Current report
2022/07/05

重要事件披露

8-K - Current report
2022/06/09

重要事件披露

8-K - Current report
2022/06/01

重要事件披露

8-K - Current report
2022/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

重要事件披露

8-K - Current report
2022/05/03

重要事件披露

8-K - Current report
2022/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/01

重要事件披露

8-K - Current report
2022/02/28

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals